Evolocumab (anti-PCSK9) | PCSK9 | Read Reviews & Product Use Citations

Evolocumab (anti-PCSK9) is a human monoclonal antibody that inhibits PCSK9. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR. Evolocumab can be used for the research of hypercholesterolemia and atherosclerotic cardiovascular diseases.

Purity & Quality Control

Batch: Purity: 99% Protein concentration: 6.47mg/ml Endotoxin Level: <1 EU/mg

99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description	Evolocumab (anti-PCSK9) is a human monoclonal antibody that inhibits PCSK9. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR. Evolocumab can be used for the research of hypercholesterolemia and atherosclerotic cardiovascular diseases.

References
[1] Fala L. Am Health Drug Benefits. 2016 Mar;9(Spec Feature):136-9.

References

[1] Fala L. Am Health Drug Benefits. 2016 Mar;9(Spec Feature):136-9.

Product Details

CAS No.	1256937-27-5
Molecular Weight	141.8 KD
Isotype	Human IgG2
Application	Evolocumab (anti-PCSK9)
Sterility	0.2 μM filtered
Formulation	PBS Buffer, PH 7.4
Storage (From the date of receipt)	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field